Provided by Tiger Fintech (Singapore) Pte. Ltd.

HCW Biologics Inc.

4.57
-0.2900-5.97%
Post-market: 4.570.00000.00%19:39 EDT
Volume:45.38K
Turnover:217.78K
Market Cap:9.50M
PE:-0.15
High:5.15
Open:4.81
Low:4.50
Close:4.86
Loading ...

S&P 500 Down Over 1%; Tyson Foods Posts Upbeat Results

Benzinga
·
03 Feb

HCW Biologics Advances with FDA Clearance for Trial

TIPRANKS
·
03 Feb

BUZZ-HCW Biologics rises as US FDA approves trial for hair loss treatment

Reuters
·
03 Feb

HCW Biologics Says FDA Approves Trial of HCW9302 to Treat Alopecia Areata; Shares Rise Pre-Bell

MT Newswires Live
·
03 Feb

HCW Biologics receives clearance of IND from FDA for HCW9302

TIPRANKS
·
03 Feb

HCW Biologics Inc - HCW9302 Shows Efficacy in Treating Autoimmune Diseases

THOMSON REUTERS
·
03 Feb

HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-in-Human Phase 1 Clinical Trial

THOMSON REUTERS
·
03 Feb

HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial

GlobeNewswire
·
03 Feb

HCW Biologics Insiders Placed Bullish Bets Worth US$2.50m

Simply Wall St.
·
23 Jan

HCW Biologics CEO to address opportunities, challenges in biomanufacturing

TIPRANKS
·
15 Jan

HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

GlobeNewswire
·
15 Jan

HCW Biologics Shares Fall Amid Delisting Notice From Nasdaq

MT Newswires Live
·
24 Dec 2024

HCW Biologics receives notice on failing to regain compliance from Nasdaq

TIPRANKS
·
23 Dec 2024

HCW Biologics Inc. Received Nasdaq Staff Determination Letter

THOMSON REUTERS
·
23 Dec 2024

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

GlobeNewswire
·
23 Dec 2024